Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic.
作者信息
Choy Kay Weng
机构信息
Department of Pathology, The Northern Hospital, Epping, VIC 3076, Australia.
出版信息
Lancet Microbe. 2020 Nov;1(7):e273-e274. doi: 10.1016/S2666-5247(20)30168-3. Epub 2020 Nov 4.
Abstract
摘要
相似文献
1
Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic.
Lancet Microbe. 2020 Nov;1(7):e273-e274. doi: 10.1016/S2666-5247(20)30168-3. Epub 2020 Nov 4.
2
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey.
Clin Chem Lab Med. 2020 Jun 4;58(9):1433-1440. doi: 10.1515/cclm-2020-0711. Print 2020 Aug 27.
3
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
Clin Chem Lab Med. 2020 Jun 4;58(9):1441-1449. doi: 10.1515/cclm-2020-0710. Print 2020 Aug 27.
4
Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):350-357. doi: 10.4103/IJPM.IJPM_857_20.
5
Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank.
Methods Mol Biol. 2019;1897:213-225. doi: 10.1007/978-1-4939-8935-5_19.
6
A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic.
Vox Sang. 2021 Jul;116(6):682-691. doi: 10.1111/vox.13051. Epub 2021 Feb 2.
7
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
Clin Chem Lab Med. 2020 Jun 25;58(7):1053-1062. doi: 10.1515/cclm-2020-0633.
8
Biosafety during a pandemic: shared resource laboratories rise to the challenge.
Cytometry A. 2021 Jan;99(1):68-80. doi: 10.1002/cyto.a.24280. Epub 2021 Jan 4.
9
Preparedness to face the COVID-19 pandemic - is India missing the mark?
J Glob Health. 2020 Dec;10(2):020338. doi: 10.7189/jogh.10.020338.
10
Biosafety Professionals: A Role in the Pandemic Response Team.
Health Secur. 2021 Jul-Aug;19(4):454-458. doi: 10.1089/HS.2021.0015.
引用本文的文献
1
Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016-2022.
Can Commun Dis Rep. 2024 May 24;50(5):144-152. doi: 10.14745/ccdr.v50i05a04.
2
Knowledge, attitude and practice of infection prevention and control precautions among laboratory staff: a mixed-methods systematic review.
Antimicrob Resist Infect Control. 2023 Jun 13;12(1):57. doi: 10.1186/s13756-023-01257-5.
3
Medical laboratory staff satisfaction and their perspective on the role of health institutions to combat COVID-19 pandemic.
J Int Med Res. 2022 Jun;50(6):3000605221105356. doi: 10.1177/03000605221105356.
4
COVID-19 cases among medical laboratory services staff in South Africa, 2020-2021: A cohort study.
PLoS One. 2022 Jun 17;17(6):e0268998. doi: 10.1371/journal.pone.0268998. eCollection 2022.
5
Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection Nanopore Whole-Genome Sequencing.
Front Cell Infect Microbiol. 2022 Mar 7;12:819829. doi: 10.3389/fcimb.2022.819829. eCollection 2022.
6
Survey of laboratory medicine's national response to the Covid-19 pandemic in the Republic of Ireland.
Ir J Med Sci. 2022 Feb;191(1):65-69. doi: 10.1007/s11845-021-02578-3. Epub 2021 Mar 4.
本文引用的文献
1
Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: A simulation study.
Clin Biochem. 2020 Dec;86:15-22. doi: 10.1016/j.clinbiochem.2020.09.003. Epub 2020 Sep 12.
2
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey.
Clin Chem Lab Med. 2020 Jun 4;58(9):1433-1440. doi: 10.1515/cclm-2020-0711. Print 2020 Aug 27.
3
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
Clin Chem Lab Med. 2020 Jun 4;58(9):1441-1449. doi: 10.1515/cclm-2020-0710. Print 2020 Aug 27.
4
Laboratory-acquired severe acute respiratory syndrome.
N Engl J Med. 2004 Apr 22;350(17):1740-5. doi: 10.1056/NEJMoa032565.
5
Laboratory-acquired SARS raises worries on biosafety.
Lancet Infect Dis. 2004 Feb;4(2):64. doi: 10.1016/s1473-3099(04)00911-9.
Zotero 插件